You are here
It gives us great pleasure to invite you to attend The International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2017) scheduled to take place in London, UK from 16-17 March 2017.
ICTO2017 will bring together world renowned speakers in the field of Clinical Trials and Oncology and Hemato-Oncology and this first congress will welcome oncology professionals, treatment experts, CRO’s, industry leaders and other experts to the majestic city of London.
ICTO2017 has all the components to provide an outstanding scientific, educational and networking experience.
The congress will focus on areas including:
Design of clinical trials in the new era
- Personalized cancer medicine
- Monitoring of Trials and Statistics
- Regulations – Survival based Medicine
- Phase 4 Trials
- Expanded access trials
- Ethics and Patients’ Rights
- Healthcare economy
Our goal is for ICTO2017 to be the forerunner in analysis, interpretation and translation of data and knowledge relating to Clinical Trials in Oncology and Hemato-Oncology.
We look forward to welcoming you as part of this exciting and dynamic Congress.